thiophenes has been researched along with Lupus Erythematosus, Systemic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Liu, A; Xiang, L; Xu, G | 1 |
Bodewes, ILA; Dalm, VASH; Groot, N; Huijser, E; Huizinga, R; Kamphuis, S; Tas, L; van Daele, PLA; van Hagen, PM; van Helden-Meeuwsen, CG; Versnel, MA | 1 |
Kim, DG; Kim, HW; Lee, SJ; Yoon, CK | 1 |
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE | 1 |
Apelgren, LD; Bailey, DL; Bryan, N; Bumol, TF; Evans, GF; Fouts, RL; Glasebrook, A; Sandusky, GE; Short, L; Zuckerman, SH | 1 |
Delmas, PD; Roudier, J | 1 |
6 other study(ies) available for thiophenes and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Topics: Animals; Autoantibodies; B-Lymphocytes; Cell Proliferation; Disease Models, Animal; Female; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice, Inbred BALB C; Signal Transduction; Spleen; Sulfonamides; Terpenes; Thiophenes; X-Box Binding Protein 1 | 2020 |
TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Topics: Adaptor Proteins, Signal Transducing; Antigens; Carrier Proteins; Cells, Cultured; Cytoskeletal Proteins; Gene Expression Regulation; Humans; Interferon Regulatory Factor-3; Interferon Regulatory Factor-7; Interferon Type I; Intracellular Signaling Peptides and Proteins; Lupus Erythematosus, Systemic; Myxovirus Resistance Proteins; Neutrophils; Phosphorylation; Protein Serine-Threonine Kinases; Pyrimidines; RNA-Binding Proteins; Scleroderma, Systemic; Signal Transduction; Sjogren's Syndrome; STAT1 Transcription Factor; Thiophenes; Toll-Like Receptor 7 | 2018 |
Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy.
Topics: Administration, Topical; Adult; Aged; Antirheumatic Agents; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angiography; Fundus Oculi; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Macular Edema; Retinal Diseases; Sulfonamides; Thiophenes; Visual Acuity | 2018 |
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin | 2014 |
The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
Topics: Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; Disease Progression; Estradiol Congeners; Estrogen Antagonists; Ethinyl Estradiol; Female; Kidney; Lupus Erythematosus, Systemic; Lymph Nodes; Mice; Mice, Inbred MRL lpr; Molecular Structure; Pyrrolidines; Receptors, Estrogen; Thiophenes; Thymus Gland | 1996 |
Tertatolol-induced lupus.
Topics: Humans; Iatrogenic Disease; Lupus Erythematosus, Systemic; Male; Middle Aged; Propanolamines; Thiophenes | 1988 |